AARON G.L. FLETCHER

Profile

First Name

: AARON

Middle Name

: G.L.

Last Name

: FLETCHER

Related Companies

Titles

Company Name

Related People

DIRECTOR

LUNG THERAPEUTICS, INC.

WILLIAM C. FAIREY, AARON FLETCHER, CHARLES GARNER, STEVEN IDELL, JIM MERVIS, ROBERT MILLS, R. A. SESSION, BRIAN WINDSOR, JAMES BRIAN WINDSOR, JOSEPH WOELKERS

DIRECTOR

BIOS SPECIAL OPPORTUNITY FUND, LP

N/A BIOS ADVISORS GP, LLC, N/A BIOS CAPITAL MANAGEMENT, LP, N/A BIOS EQUITY SOF I, LP

EXECUTIVE OFFICER

BIOS ACTUATE CO-INVEST III, LP

- BIOS ADVISORS GP, LLC, - BIOS CAPITAL MANAGEMENT, LP, - BIOS EQUITY PARTNERS III, LP, - CAVU ADVISORS, LLC, - CAVU MANAGEMENT, LP, LESLIE WAYNE KREIS JR.

EXECUTIVE OFFICER, DIRECTOR

BIOS CLINICAL OPPORTUNITY FUND, LP

- BIOS CAPITAL MANAGEMENT, LP, - BIOS EQUITY COF, LP, JOHN FUCCI, DANIEL SCHWARZ

DIRECTOR

BIOS 2024 CO-INVEST, LP

- BIOS ADVISORS GP, - BIOS CAPITAL MANAGEMENT, LP, - BIOS EQUITY COF, LP

DIRECTOR

BIOS ONL CO-INVEST II, LP

- BIOS ADVISORS GP, - BIOS CAPITAL MANAGEMENT, LP, - BIOS EQUITY COF, LP

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

PHARMACEUTICALS

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2025-06-27

D

VENTURE CAPITAL FUND

DECLINE TO DISCLOSE

Equity

2024-06-14

D

VENTURE CAPITAL FUND

DECLINE TO DISCLOSE

Equity

2024-06-14

D

VENTURE CAPITAL FUND

DECLINE TO DISCLOSE

Equity

2023-07-12

D

VENTURE CAPITAL FUND

DECLINE TO DISCLOSE

Equity

2022-09-30

D

PRIVATE EQUITY FUND

DECLINE TO DISCLOSE

Equity

2022-03-31

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2022-03-14